Taiwan FDA registration 234d52f9f407748b12a4013cc869083e
HMD Holly Blood Glucose Monitoring System
TW: 厚美德好家庭血糖檢測系統
Taiwan·Risk Class 2·MD·HMD BIOMEDICAL INC.·Registered Nov 23, 2018 – Jun 20, 2026ExpiredRegistration details
- Analysis ID
- 234d52f9f407748b12a4013cc869083e
- License Form
- Ministry of Health Medical Device Manufacturing No. 006267
Company information
- Manufacturer
- HMD BIOMEDICAL INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- HMD BIOMEDICAL INC.
Product details
- Intended Use
- This product is made using electrochemical biosensing technology and can only be used with Omega Good Thing Blood Glucose Test Tablets to provide diabetic patients with home detection of microvascular whole blood glucose levels. And under the operation of professionals, the blood glucose value of adult microvascular, venous blood and newborn babies can be measured.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Nov 23, 2018
- Expiry Date
- Jun 20, 2026
About this record
Access comprehensive regulatory information for HMD Holly Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 234d52f9f407748b12a4013cc869083e and manufactured by HMD BIOMEDICAL INC.. The authorized representative in Taiwan is HMD BIOMEDICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices